The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 369K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valiante, N. M.
Right arrow Articles by Parham, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valiante, N. M.
Right arrow Articles by Parham, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1996/12/2243/ $5.00
The Journal of Experimental Medicine, Volume 184, Number 6, December 1, 1996 2243-2250


Articles

Killer Cell Inhibitory Receptor Recognition of Human Leukocyte Antigen (HLA) Class I Blocks Formation of a pp36/PLC-{gamma} Signaling Complex in Human Natural Killer (NK) Cells

Nicholas M. Valiante*, Joseph H. Phillips{ddagger}, Lewis L. Lanier{ddagger}, and Peter Parham*

From the * Departments of Structural Biology and Microbiology & Immunology, Stanford University Medical School, Stanford, California 94305; and the {ddagger} Department of Human Immunology, DNAX Research Institute for Molecular and Cellular Biology, Palo Alto, California 94304

The killer cell inhibitory receptors (KIR) of human natural killer (NK) cells recognize human leukocyte antigen class I molecules and inhibit NK cell cytotoxicity through their interaction with protein tyrosine phosphatases (PTP). Here, we report that KIR recognition of class I ligands inhibits distal signaling events and ultimately NK cell cytotoxicity by blocking the association of an adaptor protein (pp36) with phospholipase C-{gamma} in NK cells. In addition, we demonstrate that pp36 can serve as a substrate in vitro for the KIR-associated PTP, PTP-1C (also called SHP-1), and that recognition of class I partially disrupts tyrosine phosphorylation of NK cell proteins, providing evidence for KIR-induced phosphatase activity.


Address correspondence to Dr. Peter Parham, Department of Structural Biology, Sherman Fairchild Building, D157, Stanford University Medical School, Stanford, CA 94305.

The authors wish to thank Dr. S. Cooper and Dr. G. Koretzky for their critical reading of the manuscript.

This research was supported by National Institutes of Health grant AI22039 to P. Parham. N.M. Valiante is a fellow of the Cancer Research Institute. DNAX Research Institute for Molecular and Cellular Biology is supported by Schlering Plough Corporation.

1 Abbreviations used in this paper: GST, glutathione-S-transferase; IP3, inositol 1,4,5-triphosphate; KIR, killer cell inhibitory receptors; PIP2, phosphatidylinositol 4,5-bisphosphate; PLC, phospholipase C; PTK, protein tyrosine kinase; PTP, protein tyrosine phosphatases.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS